×
The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
×
A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes PDF
$ 40.00
A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes PDF quantity
$ 40.00
×
Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder: An Open-Label Trial Followed by a Double-Blind Discontinuation Phase PDF
$ 40.00
Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder: An Open-Label Trial Followed by a Double-Blind Discontinuation Phase PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
